I'm looking
for help...
Aidpage is free!

Free downloads: GrantGate®  Federal Money Retriever®

Strategic Program for Innovative Research on Drug Addiction Pharmacotherapy (SPIRDAP)

Published on AidPage by IDILOGIC on Jun 24, 2005
Administered by:

Department of Health and Human Services, National Institutes of Health, National Institutes of Health
(see all US Federal Agencies)

Explore all postings for this grant program:
  • Original Grant - Feb 9, 2005
Applications Due:

Apr 18, 2005

total funding: $2,000,000
max award: none
min award: none
cost sharing, matching: No
number of awards: 3
type of funding: Cooperative Agreement

The National Institute on Drug Abuse (NIDA) invites applications to support innovative, integrated preclinical and clinical research to validate novel pharmacotherapeutic approaches and to identify potential compounds that are safe and effective, short-term (to reduce and stop drug use) and long-term (to prolong abstinence) pharmacotherapies for cocaine, methamphetamine and cannabinoid addiction. Significant progress in molecular biology, cell biology, genetics, immunology, neuroscience and behavioral sciences has provided the scientific basis for the development of innovative pharmacological interventions for drug addiction. The Strategic Program for Innovative Research on Drug Addiction Pharmacotherapy (SPIRDAP) encourages a collaborative enterprise between preclinical and clinical scientists in the conceptualization and proof-of-concept of a pharmacotherapeutic strategy. Novel approaches are of interest for the development of pharmacotherapies for c!
ocaine, methamphetamine or cannabinoid addiction treatments which are based on molecular targets for specific receptor subtypes, transporters, intracellular organelles or metabolic pathways to modulate the neurotransmitter systems involved in the drug addiction processes. The applicant must possess the expertise necessary to (i) evaluate the proposed strategy in preclinical systems, and (ii) implement early phase clinical studies in volunteers or target populations to validate the therapeutic modality. The participation of commercial (pharmaceutical, chemical, or biotechnological) organizations is strongly encouraged.

Who can apply:

Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Quasi-Public Nonprofit Institution/Organization
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)

Eligible functional categories:
Funding Sources:

Drug Abuse Research Programs

More Information:


If you have problems accessing the full announcement, please contact: NIH OER Webmaster

Address Info:

Free downloads: GrantGate®  Federal Money Retriever®
Apply for grants and loans! Click here to start